“`html
Investors in BioMarin Pharmaceutical Inc (BMRN) gained access to new options expiring in August 2026 on October 5, 2023. A put contract at a $50.00 strike price currently has a bid of $3.70, allowing sellers to effectively lower their cost basis to $46.30 if exercised, representing a 12.03% discount to today’s trading price of $52.73 per share.
Additionally, a call contract at the $55.00 strike price has a current bid of $5.40. Selling this call would yield a total return of 14.55% if exercised by expiration, which is a 4% premium over the current stock price. The odds of both the put and call contracts expiring worthless are 66% and 44%, respectively, based on current analytical data.
“`
